Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD

Open access
Tamaki, Nobuharu, Ajmera, Veeral, Loomba, Rohit · 2022 · Nature Reviews Endocrinology

Abstract

Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD). The non-invasive quantification of liver fat is now possible due to advances in imaging modalities. Emerging data suggest that high levels of liver fat and its temporal change, as measured by quantitative non-invasive methods, might be associated with NAFLD progression. Ultrasound-based modalities have moderate diagnostic accuracy for liver fat content and are suitable for screening. However, of the non-invasive imaging modalities, MRI-derived proton density fat fraction (MRI-PDFF) has the highest diagnostic accuracy and is used for trial enrolment and to evaluate therapeutic effects in early-phase clinical trials in nonalcoholic steatohepatitis (NASH). In patients with NAFLD without advanced fibrosis, high levels of liver fat are associated with rapid disease progression. Furthermore, changes on MRI-PDFF (≥30% decline relative to baseline) are associated with NAFLD activity score improvement and fibrosis regression. However, an inverse association exists between liver fat and complications of cirrhosis. Liver fat decreases as liver fibrosis progresses towards cirrhosis, and the clinical importance of quantitative measurements of liver fat differs by NAFLD status. As such, patients with NAFLD should be stratified by fibrosis severity to investigate the utility of quantitative measurements of liver fat for assessing NAFLD progression and prognosis. Imaging modalities are now available that enable non-invasive quantitative measurements of liver fat content. This Review highlights the various modalities and their use in clinical trials, discusses the clinical importance of hepatic steatosis for progression of nonalcoholic fatty liver disease and proposes how the new modalities might be used going forward. Ultrasound-based modalities for the quantification of liver fat content have moderate diagnostic accuracy for the degree of hepatic steatosis and are useful as a pre-screen strategy in clinical trials in nonalcoholic steatohepatitis (NASH). Compared with other imaging modalities, MRI-derived proton density fat fraction (MRI-PDFF) has the highest diagnostic accuracy for quantification of liver fat content and is commonly used in trials in NASH. Increased liver fat content (MRI-PDFF ≥15%) is associated with increased odds of fibrosis progression in patients with NAFLD at an early stage of fibrosis. In patients with NAFLD, change in MRI-PDFF (≥30% decline relative to baseline) is associated with a histological response (NAFLD activity score ≥2 points improvement with no worsening of fibrosis) and fibrosis regression (reduction of one or more stages). Decreased liver fat content is associated with an increased incidence of liver-related events and poor prognosis in patients with NASH with advanced fibrosis. Liver fat content decreases in the setting of cirrhosis; therefore, the clinical importance of quantitative assessment of liver fat content and its change over time differs by NAFLD disease status and fibrosis severity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-021-00584-0

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 251

Metadata

Authors
Tamaki, N., Ajmera, V., & Loomba, R.
Venue
Nature Reviews Endocrinology
Published
2021-11-23
Volume
18
Issue
1
Pages
55-66
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W3214932937
Cited by
251
References
29
FWCI
7.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. https://app.cochat.ai/papers/10.1038/s41574-021-00584-0
The paper
Tamaki, N., Ajmera, V., & Loomba, R. (2022). Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-021-00584-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.